Skip to content

Attovia Therapeutics, Inc.

ATTO· NasdaqCore metricsCIK 2058707

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -5.04%
Market cap
$723.63M
45.71M shares
Filings
61
$0.00
Q3 2026
—
-$22.27M
Q3 2026
—
-$25.02M
Q3 2026
—
-$60.98M
Q3 2026derived
—
-$0.76
Q3 2026
—
$115.37M
Q3 2026+28.7% FY25 yoy
$723.63M
—
—
1.8×
—
—

FY2026 figures · derived

Price

$15.8327.72%$6.07since Aug 5, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00Q3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Biological products, except diagnostic substances

Attovia Therapeutics, Inc. is the 52nd largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Attovia Therapeutics, Inc. · CIK 2058707 · Engraved from SEC EDGAR